Freudenberg Medical has announced several new options for medical device companies looking to accelerate time to market.
The Composer XL Deflectable Catheter Handle Platform offers a commercialization-ready interface to provide integrated control and has been sized for large bore structural heart and endovascular devices such as transcatheter tricuspid and mitral valve delivery systems.
Meanwhile, the HyperSeal XL, is a new member to the hemostasis valve family, designed to provide a robust design option for vascular access applications up to 30Fr and 40Fr. Also making their debut this year’s are the 8.5F and 12Fr Composer Steerable Introducers, new finished device solutions for private label development and customization for a range of electrophysiology, structural heart and vascular applications.
“Freudenberg Medical’s new ComposerXL and HyperSeal XL were developed to address the unique challenges with large bore vascular access and device delivery in the rapidly evolving transcatheter valve and endovascular space. The significantly larger size of these emerging therapeutic devices are demanding innovative and unconventional solutions to reduce risk and improve outcomes,” said Bernie Kaeferlein, director of portfolio management at Freudenberg Medical. “As a partner for innovation, we are committed to proactively addressing unmet clinical needs and offering our medical device customers a growing portfolio of finished device, design, and process solutions to help improve efficiency and accelerate their time to market.“